News & Perspective

Sep 09, 2002

Sep 09, 2002

Anthrax decontamination workers should get vaccine or antibiotics, CDC says

(CIDRAP News) – Workers who decontaminate buildings tainted with anthrax (Bacillus anthracis) spores should be vaccinated against the disease or receive preventive antibiotic treatment, according to new guidelines from the Centers for Disease Control and Prevention (CDC).

Jul 01, 2002

Jul 01, 2002

Pentagon will turn over part of anthrax vaccine supply for civilian use

July 1, 2002 (CIDRAP News) – About half of the nation's supply of anthrax vaccine—previously dedicated almost entirely to military use—will henceforward be set aside for civilian use in the event of another anthrax attack, federal defense and health officials announced Jun 28.

May 31, 2002

May 31, 2002

Smallpox vaccination policy: CDC sets meeting schedule, seeks electronic input

(CIDRAP News) – In their initiative to take the public's pulse on smallpox immunization policy, federal health officials have announced the schedule for five upcoming public forums and have set up a Web page to gather comments on policy options.

Mar 07, 2002

Mar 07, 2002

IOM says anthrax vaccine is safe and effective but needs improvement

(CIDRAP News) – A committee of the Institute of Medicine (IOM) has concluded after 17 months of study that the existing anthrax vaccine is effective and "acceptably safe," but a new vaccine that requires fewer doses and that causes fewer reactions is needed.

Jan 11, 2002

Jan 11, 2002

CDC proposing to use immune globulin as treatment for severe anthrax

(CIDRAP News) – Federal health officials revealed this week that they are working on a plan to use immune globulin derived from the blood of anthrax-vaccinated military personnel for emergency treatment of patients with severe cases of inhalational anthrax, if needed.

Pages

by Topic

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»